Drug & Food Allergy
Drug & Food Allergy
General Considerations
Some drugs are clearly more immunogenic than others, and 
this can be reflected in the incidence of drug hypersensitivity. A partial list 
of drugs frequently implicated in drug reactions includes B-lactam antibiotics, 
sulfonamides, phenytoin, carbamazepine, allopurinol, muscle relaxants used for 
general anesthesia, nonsteroidal anti-inflammatory drugs, antisera, and 
antiarrhythmic agents. Many drugs can be associated with recognizable known 
toxicities, drug interactions, or idiosyncratic reactions that are not 
immune-mediated. These must be distinguished from true hypersensitivity 
reactions because the prognosis and management differ. Some estimate that only 
10% or less of adverse reactions to drugs are true hypersensitivity reactions. 
Patients with multidrug hypersensitivity are quite rare, and those reporting 
"allergies" to more than three distinct classes of drugs should be carefully 
evaluated since intolerance to many of these drug classes may not be 
immunologic.
Four foods account for 90% of food allergy in adults: 
peanuts, tree nuts, fish, and shellfish. Food hypersensitivity must be 
distinguished from food intolerance, which is more common and more variable in 
terms of underlying mechanism. An example of food intolerance would be lactose 
intolerance, which is due to an enzyme deficiency rather than an IgE-mediated 
hypersensitivity.
Clinical Findings of Drug & Food Allergy
Symptoms and Signs
The development of symptoms and the nature of the adverse 
drug reaction can suggest whether an immunologic process is responsible for 
symptoms. Factors to consider include type of symptoms, history of previous drug 
exposure, time of onset after starting the drug, presence of other systemic 
involvement, coexisting illness, and concurrent drug use. In previously 
sensitized individuals, immediate hypersensitivity is manifested by rapid 
development of urticaria, angioedema, or anaphylaxis. Delayed onset of urticaria 
accompanied by fever, arthralgias, and nephritis may indicate the development of 
an immune complex-mediated disorder. Drug fever and Stevens-Johnson syndrome 
probably act by immune hypersensitivity mechanisms. In genetically slow 
acetylators and in AIDS patients with depleted hepatic glutathione levels, drugs 
such as sulfamethoxazole are not rapidly excreted during drug metabolism. This 
altered drug metabolism favors the generation of haptenated immunoreactive 
metabolites as well as drug reactions, such as delayed morbilliform eruptions. 
Other types of immune-mediated dermatologic drug reactions include lupus-like 
syndromes caused by procainamide, isoniazid, phenytoin, or hydralazine. Drugs 
that have been associated with the development of systemic or cutaneous 
vasculitis include leukotriene receptor antagonists, allopurinol, phenytoin, 
thiazides, nonsteroidal anti-inflammatory drugs, furosemide, cimetidine, gold, 
hydralazine, and many antibiotics (eg, penicillin, sulfonamides, quinolones, and 
tetracycline). Cutaneous vasculitides are usually associated with fixed lesions, 
with histologically-proven immune-complex involvement.
Food hypersensitivity is manifest by symptoms 
consistent with IgE-mediated immediate hypersensitivity/anaphylaxis but 
commonly is also accompanied by abdominal pain, nausea, vomiting, or diarrhea. 
More rarely, atopic dermatitis may be the sole clinical expression of 
food allergy. The onset of allergic food reactions is rapid, usually within 
minutes to a couple of hours of ingestion, and the reaction is usually quite 
reproducible. Oral allergy syndrome is a self-limited form of fruit and 
vegetable hypersensitivity, where symptoms are confined to the oropharynx. Due 
to cross-reactivity between certain fruit and vegetable allergens and certain 
seasonal pollens, ingestion of these foods causes a contact allergy with 
pruritus of lips, tongue, and palate typically without other symptoms or signs 
of systemic anaphylaxis. The most common cross-reacting foods and pollens are 
apples and carrots, which cross-react with birch pollen; melons and bananas, 
which cross-react with ragweed pollen. Many of these antigens involved in oral 
allergy syndrome are heat labile and denature during cooking. Immunologic 
cross-reactivity appears to also underlie the association of latex allergy and 
hypersensitivity to avocado, banana, chestnut, kiwi, and papaya. Unlike the oral 
allergy syndrome, however, systemic anaphylaxis upon ingestion of these foods 
may develop in 35–50% of patients who are allergic to latex (so called 
latex-fruit syndrome).
Laboratory Findings
Allergy testing
Allergy skin testing is only available for a limited number 
of drugs (penicillin, insulin, streptokinase, chymopapain, heterologous serum), 
since patients may react to the native drug as well as any metabolite that 
covalently binds to native protein and becomes immunoreactive. Skin testing is 
available for patients with suspected immediate hypersensitivity to penicillin 
or  -lactam 
antibiotics (see Infectious Diseases: Common Problems & Antimicrobial 
Therapy). The degree of cross-reactivity between the cephalosporin antibiotics 
and penicillins is uncertain. The incidence of IgE-mediated hypersensitivity 
appears to be less than 5%. There appears to be no allergic cross-reactivity 
between the monobactam antibiotics (aztreonam) and penicillin or other
-lactam 
antibiotics (see Infectious Diseases: Common Problems & Antimicrobial 
Therapy). The degree of cross-reactivity between the cephalosporin antibiotics 
and penicillins is uncertain. The incidence of IgE-mediated hypersensitivity 
appears to be less than 5%. There appears to be no allergic cross-reactivity 
between the monobactam antibiotics (aztreonam) and penicillin or other  -lactam 
antibiotics. A high degree of cross-reactivity exists between penicillin and the 
carbapenem, imipenem, so this drug should be given to the penicillin-allergic 
patient with the same degree of caution as if the patient were to receive 
penicillin.
-lactam 
antibiotics. A high degree of cross-reactivity exists between penicillin and the 
carbapenem, imipenem, so this drug should be given to the penicillin-allergic 
patient with the same degree of caution as if the patient were to receive 
penicillin.
 -lactam 
antibiotics (see Infectious Diseases: Common Problems & Antimicrobial 
Therapy). The degree of cross-reactivity between the cephalosporin antibiotics 
and penicillins is uncertain. The incidence of IgE-mediated hypersensitivity 
appears to be less than 5%. There appears to be no allergic cross-reactivity 
between the monobactam antibiotics (aztreonam) and penicillin or other
-lactam 
antibiotics (see Infectious Diseases: Common Problems & Antimicrobial 
Therapy). The degree of cross-reactivity between the cephalosporin antibiotics 
and penicillins is uncertain. The incidence of IgE-mediated hypersensitivity 
appears to be less than 5%. There appears to be no allergic cross-reactivity 
between the monobactam antibiotics (aztreonam) and penicillin or other  -lactam 
antibiotics. A high degree of cross-reactivity exists between penicillin and the 
carbapenem, imipenem, so this drug should be given to the penicillin-allergic 
patient with the same degree of caution as if the patient were to receive 
penicillin.
-lactam 
antibiotics. A high degree of cross-reactivity exists between penicillin and the 
carbapenem, imipenem, so this drug should be given to the penicillin-allergic 
patient with the same degree of caution as if the patient were to receive 
penicillin.
If the likelihood of immunologic reaction is low—based on 
the history and the assessment of likely offending agents—and if no allergy 
testing is available, judicious test dose challenges may be considered in a 
monitored setting. If the likelihood of IgE-mediated reaction is significant, 
these challenges are risky and rapid drug desensitization is indicated.
The gold standard for allergy food testing is skin-prick 
testing with actual food items, but due to the inconvenience and potential risk 
for systemic reactions, this form of testing is usually preceded by IgE RAST 
testing or skin prick testing with commercially available extracts or both. Food 
allergy testing must be interpreted within the context of the clinical picture, 
since false-positive tests can occur.
Provocation tests
Occasionally, direct allergen challenge of the target organ 
or tissue under controlled conditions is required for definitive diagnosis. Such 
challenges may be bronchial, nasal, conjunctival, oral, or cutaneous. A positive 
test confirms that the test substance can cause the reaction, but it does not 
prove that an immunologic mechanism is responsible.
In most cases of suspected allergy to a food or drug, 
placebo-controlled oral challenge is the definitive test. To be considered a 
positive result, the reported clinical findings must be reproduced during 
provocation testing. A blinded provocation test may be preceded by an open 
challenge (no placebo control), which, if negative, negates the necessity for 
logistically difficult blinded challenge. Freeze-dried foods in large opaque 
capsules provide a sufficient dose of allergen for testing. This should not be 
done in patients with suspected food- or drug-induced anaphylaxis.
Treatment
For IgE-mediated drug hypersensitivity, acute rapid 
desensitization may allow administration of a drug if there is no suitable 
alternative treatment regimen. This procedure carries a significant risk and 
should be undertaken in an intensively monitored setting. This is accomplished 
by a course of oral or parenteral doses starting with extremely low doses 
(dilutions of 1 x 10–6 or 1 x 
10–5 units) and increasing to the full dose over a period of hours. 
IgE-mediated reactivity diminishes during the course of this desensitization, 
creating a temporary drug-specific refractory state. During the refractory 
period, skin histamine responsiveness is maintained, and mast cells may be 
activated by other stimuli but the patient may receive the desired drug with a 
very low risk of anaphylaxis. Acute rapid desensitization may work through 
cellular mechanisms different from those involved in standard injection 
immunotherapy, and the refractory period is maintained only throughout the 
course of uninterrupted therapy.
Various slow desensitization protocols have been developed 
for patients suffering from late-appearing morbilliform eruptions (eg, AIDS 
patients with sulfamethoxazole-induced dermatitis). These eruptions are not 
IgE-mediated, and the slow reintroduction of drug allows for less haptenation 
during sulfonamide metabolism with generation of less immunoreactive drug 
metabolites. This form of desensitization is distinct from rapid desensitization 
of IgE-mediated drug allergy. Desensitization for non–IgE-mediated drug 
reactions has been successful for aspirin, nonsteroidal anti-inflammatory drugs, 
and allopurinol.
Any history or finding consistent with toxic epidermal 
necrolysis or Stevens-Johnson syndrome would be an absolute contraindication for 
drug readministration.
For any proven food hypersensitivity, strict avoidance is 
the only rational recommendation. Patients should also be provided with an 
epinephrine autoinjector (Epi-pen) if indicated.
I hope, Drug & Food Allergy article be usefull for your.
 Recources:
Current Medical Diagnosis & Treatment 2008
Stephen J. McPhee, Maxine A. Papadakis, and Lawrence M. Tierney, Jr., Eds. Ralph Gonzales, Roni Zeiger, Online Eds.
Current Medical Diagnosis & Treatment 2008
Stephen J. McPhee, Maxine A. Papadakis, and Lawrence M. Tierney, Jr., Eds. Ralph Gonzales, Roni Zeiger, Online Eds.
 
 
 
